Latest news with #BrettIcahn
Reuters
3 hours ago
- Business
- Reuters
Icahn representations resign Bausch + Lomb board after agreement termination
Aug 18 (Reuters) - Contact lens maker Bausch + Lomb ( opens new tab said on Monday Brett Icahn and Gary Hu have resigned from its board of directors after the termination of the agreement with billionaire investor Carl Icahn and some of his affiliates. The agreement, dated June 21, 2022, ended after the Icahn group's net long position in Bausch Health Companies ( opens new tab, Bausch + Lomb's parent, fell below the required threshold. On Friday, Bausch Health said Paulson Capital, along with certain affiliates and managed funds, acquired about 34.7 million common shares previously held by the Icahn Group, and now owns about 19.13% of the company's outstanding common shares. The company added Brett Icahn and Steven Miller resigned from Bausch Health's board, following the termination of a separate director appointment and nomination agreement dated February 23, 2021. In April, Carl Icahn had built an economic interest covering about 34% of Bausch Health's shares. Bausch Health separated Bausch + Lomb into another publicly listed company in 2022 while retaining a majority stake. It holds an 87.7% stake, according to data compiled by LSEG.
Yahoo
3 hours ago
- Business
- Yahoo
Bausch + Lomb board members resign after Icahn agreement ends
(Reuters) -Bausch + Lomb said on Monday Brett Icahn and Gary Hu have resigned from its board of directors after the termination of the agreement with billionaire Carl Icahn and some of his affiliates. The agreement, dated June 21, 2022, ended after the Icahn group's net long position in Bausch Health Companies, Bausch + Lomb's parent, fell below the required threshold. On Friday, Bausch Health said Paulson Capital, along with certain affiliates and managed funds, increased their position in the company and acquired about 34.7 million common shares previously held by the Icahn Group. In April, Carl Icahn had built an economic interest covering about 34% of Bausch Health's shares. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Reuters
4 hours ago
- Business
- Reuters
Bausch + Lomb board members resign after Icahn agreement ends
Aug 18 (Reuters) - Bausch + Lomb ( opens new tab said on Monday Brett Icahn and Gary Hu have resigned from its board of directors after the termination of the agreement with billionaire Carl Icahn and some of his affiliates. The agreement, dated June 21, 2022, ended after the Icahn group's net long position in Bausch Health Companies ( opens new tab, Bausch + Lomb's parent, fell below the required threshold. On Friday, Bausch Health said Paulson Capital, along with certain affiliates and managed funds, increased their position in the company and acquired about 34.7 million common shares previously held by the Icahn Group. In April, Carl Icahn had built an economic interest covering about 34% of Bausch Health's shares.
National Post
4 hours ago
- Business
- National Post
Bausch + Lomb Announces Board Changes
Article content VAUGHAN, Ontario — Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the Amended and Restated Director Appointment and Nomination Agreement, dated as of June 21, 2022, by and among the company and Mr. Carl C. Icahn and certain of his affiliates, terminated pursuant to its terms when the Icahn group's net long position in the common shares of Bausch + Lomb's parent company, Bausch Health Companies Inc., fell below the required threshold. In connection with the termination, Brett M. Icahn and Gary Hu have resigned from the Bausch + Lomb Board of Directors. Article content 'I appreciate Brett and Gary's valuable contributions to the company over the past three years, and wish them well going forward,' said Brent Saunders, chairman and CEO, Bausch + Lomb. Article content Article content About Bausch + Lomb Article content Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from birth through every phase of life. Its comprehensive portfolio of approximately 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,500 employees and a presence in approximately 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario, with corporate offices in Bridgewater, New Jersey. For more information, visit Article content , Article content Instagram Article content , Article content LinkedIn Article content , Article content X Article content and Article content YouTube Article content . Article content © 2025 Bausch + Lomb Article content Article content Article content Article content Article content Contacts Article content Media Contact: Article content Article content Chris Clark Article content Article content Article content Article content (848) 360-1100 Article content Investor Contact: Article content Article content George Gadkowski Article content Article content Article content
Yahoo
30-07-2025
- Business
- Yahoo
CVR Energy names Mark Pytosh as CEO, adds Brett Icahn to board
(Reuters) -Carl Icahn-backed CVR Energy on Wednesday named Mark Pytosh as chief executive officer and appointed Brett Icahn to its board. Pytosh will assume the top role effective January 1, 2026, succeeding Dave Lamp, who announced plans to retire from the position effective December 31. Icahn's activist investment firm Icahn Enterprises currently holds a 68.5% stake in the U.S. refiner and is working to further boost its ownership to 84%. Brett Icahn is the son of billionaire Carl Icahn. He will join the refiner's board, effective August 1. The activist investor believes CVR's shares are undervalued in the market and represent an attractive investment opportunity at a time when U.S. refining margins have slumped from the highs reached in 2022. The company also reported a net loss of $114 million for the second quarter, compared with a year-ago profit of $21 million. Its shares fell 4.5% after the bell. Sign in to access your portfolio
